Altos Labs
Bay Area, US · 3 known investors
Altos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.
Founders & leadership
RM
Richard MurrayCEO and Founder
SY
Shinya YamanakaChief Scientific Advisor and Founder
Investors · 3
Acquisitions · 1
Early investors' stakes continue via these dealsDorian Therapeutics
Altos Labs focuses on cell rejuvenation to restore cell health and resilience, with the goal of reversing disease, injury, and associated disabilities. The company translates cell biology research into therapeutic interventions.
In the news
- 5 largest VC rounds of H1 2026 - BioSpacebiospace.com · 2026
- Why billionaires could reverse ageing for everyone – but keep refusing to | BBC Science Focus Magazinesciencefocus.com · 2026
- Sell or Invest in Altos Labs Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Buy Altos Labs stock and other Pre-IPO shares on UpMarketupmarket.co · 2023
- Despite blockbuster Altos funding, longevity-focused investment drops by $1B: reportfiercebiotech.com · 2023
- Biotech Altos Labs emerges with $3B in funding to focus on 'cellular rejuvenation programming' - Drug Discovery and Developmentdrugdiscoverytrends.com · 2022